IDXG 0.85 (-68.52%)
US46062X3035• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. IDXG

Interpace Biosciences (IDXG) Competitor Comparison

We are evaluating the key criteria listed to compare Interpace Biosciences (IDXG) against its competitors in the Diagnostics & Research industry.

Market Capitalization

57 / 58

Gross Profits

45 / 52

Total Revenue

45 / 57

EBITDA

27 / 56

Free Cashflow

28 / 56

Quick Ratio

50 / 57

Earnings per Share

19 / 55

Dividend yield

0 / 8

Total Cash

52 / 57

Performance 3 years

53 / 58

Performance 5 years

50 / 58

Performance 10 years

57 / 58

Linearity 3 years

49 / 58

Linearity 5 years

41 / 58

Linearity 10 years

42 / 58

Total Rank

17 / 58

Dividend Rank

12 / 58

Valuation Rank

49 / 58

Piotroski Rank

22 / 58

Muliplier Rank

4 / 58

Linearity 3 years - IDXG ranking 49 / 58

These are the competitors of Interpace Biosciences in the industry Diagnostics & Research ranked by linearity 3 years
1. Laboratory Corp of America Holdings LH
83.39
2. Agilent Technologies A
38.13
3. Ortho Clinical Diagnostics Holdings OCDX
33.4
4. Quest Diagnostics DGX
28.52
5. Qiagen QGEN
24.81
6. Thermo Fisher Scientific TMO
22.12
7. Danaher DHR
20.07
8. PerkinElmer PKI
16.14
9. Waters WAT
12.62
10. Icon ICLR
11.4
11. IQVIA Holdings IQV
10.96
12. Syneos Health SYNH
10.68
13. Mettler-Toledo MTD
9.77
14. Sera Prognostics SERA
9.52
15. IDEXX Laboratories IDXX
9.39
16. Heska HSKA
7.67
17. Anixa Biosciences ANIX
7.21
18. DexCom DXCM
7.12
19. Olink Holding OLK
6.67
20. Exact Sciences EXAS
6.62
21. Twist Bioscience TWST
5.25
22. Sotera Health SHC
4.57
23. National Research NRC
4.38
24. Myriad Genetics MYGN
4.29
25. Global Cord Blood CO
4.22
26. MaxCyte MXCT
3.85
27. NeoGenomics NEO
3.82
28. Charles River Laboratories CRL
3.65
29. Bioventus BVS
3.43
30. CareDx CDNA
2.96
31. Psychemedics PMD
2.77
32. Guardant Health GH
2.76
33. Enzo Biochem ENZ
2.57
34. Neogen NEOG
2.45
35. Illumina ILMN
2.41
36. Pacific Biosciences of California PACB
2.35
37. MDxHealth MDXH
2.19
38. Exagen XGN
2.17
39. Fulgent Genetics FLGT
2.13
40. Personalis PSNL
2.03
41. Trinity Biotech TRIB
2
42. Precipio PRPO
2
43. Biodesix BDSX
1.99
44. Medpace Holdings MEDP
1.98
45. Neuronetics STIM
1.98
46. DarioHealth DRIO
1.79
47. Organovo Holdings ONVO
1.79
48. Co-Diagnostics CODX
1.7
49. Interpace Biosciences IDXG
1.68
50. Inotiv NOTV
1.62
51. Prenetics Global PRE
1.55
52. bioAffinity Technologies BIAF
1.55
53. SeqLL SQL
1.48
54. Aspira Womens Health AWH
1.38
55. Lantheus Holdings LNTH
1.14
56. RadNet RDNT
0.8
57. Meridian Bioscience VIVO
0.73
58. Natera NTRA
0.39
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.